114 filings
IRAN
GSK
GSK Plc
5 Mar 24
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
12:30pm
SD
GSK
GSK Plc
30 May 23
Conflict minerals disclosure
2:24pm
EFFECT
Glaxosmithkline Capital Inc
16 Mar 23
Notice of effectiveness
12:15am
IRAN
GSK
GSK Plc
10 Mar 23
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
11:22am
SD
GSK
GSK Plc
27 May 22
Conflict minerals disclosure
4:04pm
IRAN
vmvfe8 96
8 Mar 22
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1:21pm
UPLOAD
df4 x485ci89
8 Sep 21
Letter from SEC
12:00am
CORRESP
l3kuso0
31 Aug 21
Correspondence with SEC
12:00am
UPLOAD
bdm9q06g
18 Aug 21
Letter from SEC
12:00am
SD
a1hua y93atd
27 May 21
Conflict minerals disclosure
4:11pm
IRAN
3g3ayjoqd m82t29c85
12 Mar 21
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3:44pm
CERT
nhab4k29
7 Oct 20
Certification of approval for exchange listing
10:33am
SD
7f5ot0v2tkawwt663hxv
29 May 20
Conflict minerals disclosure
4:10pm
IRAN
tfcv74z0vpt0g8s4q
6 Mar 20
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
4:10pm
EFFECT
mkm7lvi 07k
30 Jul 19
Notice of effectiveness
12:15am
SD
rt1g1yw
31 May 19
Conflict minerals disclosure
2:04pm
CT ORDER
u3o4x
2 May 19
Confidential treatment order
4:12pm
CERT
5chv0y20uxs9w91dh qd
29 Mar 19
Certification of approval for exchange listing
9:02am
IRAN
c1k4unp z1u2zk
15 Mar 19
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
4:25pm
SD
9vp yfu8fci
30 May 18
Conflict minerals disclosure
2:21pm